These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9144408

  • 1. Action mechanism of retinoid-synergistic dibenzodiazepines.
    Umemiya H, Kagechika H, Fukasawa H, Kawachi E, Ebisawa M, Hashimoto Y, Eisenmann G, Erb C, Pornon A, Chambon P, Gronemeyer H, Shudo K.
    Biochem Biophys Res Commun; 1997 Apr 07; 233(1):121-5. PubMed ID: 9144408
    [Abstract] [Full Text] [Related]

  • 2. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.
    Umemiya H, Fukasawa H, Ebisawa M, Eyrolles L, Kawachi E, Eisenmann G, Gronemeyer H, Hashimoto Y, Shudo K, Kagechika H.
    J Med Chem; 1997 Dec 19; 40(26):4222-34. PubMed ID: 9435893
    [Abstract] [Full Text] [Related]

  • 3. [Retinoid antagonists].
    Umemiya H, Kagechika H, Fukasawa H, Hashimoto Y, Shudo K.
    Yakugaku Zasshi; 1996 Dec 19; 116(12):928-41. PubMed ID: 8993231
    [Abstract] [Full Text] [Related]

  • 4. Retinoid X receptor-antagonistic diazepinylbenzoic acids.
    Ebisawa M, Umemiya H, Ohta K, Fukasawa H, Kawachi E, Christoffel G, Gronemeyer H, Tsuji M, Hashimoto Y, Shudo K, Kagechika H.
    Chem Pharm Bull (Tokyo); 1999 Dec 19; 47(12):1778-86. PubMed ID: 10748721
    [Abstract] [Full Text] [Related]

  • 5. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
    Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP.
    Blood; 1996 Mar 01; 87(5):1977-84. PubMed ID: 8634447
    [Abstract] [Full Text] [Related]

  • 6. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD, Brouillette WJ, Alam M, Vaezi MF, Sani BP, Venepally P, Reddy L, Li E, Norris AW, Simpson-Herren L, Hill DL.
    J Med Chem; 1996 Sep 13; 39(19):3625-35. PubMed ID: 8809153
    [Abstract] [Full Text] [Related]

  • 7. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY, Dawson MI, Walsh GL, Nesbitt JC, Eckert RL, Fuchs E, Hong WK, Lotan R, Kurie JM.
    Cell Growth Differ; 1996 Aug 13; 7(8):997-1004. PubMed ID: 8853895
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H, Sévilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T.
    Leukemia; 1997 Feb 13; 11(2):221-7. PubMed ID: 9009084
    [Abstract] [Full Text] [Related]

  • 9. Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands.
    Hara M, Suzuki S, Mori J, Yamashita K, Kumagai M, Sakuma T, Kakizawa T, Takeda T, Miyamoto T, Ichikawa K, Hashizume K.
    Thyroid; 2000 Dec 13; 10(12):1023-34. PubMed ID: 11201846
    [Abstract] [Full Text] [Related]

  • 10. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
    Vu-Dac N, Gervois P, Torra IP, Fruchart JC, Kosykh V, Kooistra T, Princen HM, Dallongeville J, Staels B.
    J Clin Invest; 1998 Aug 01; 102(3):625-32. PubMed ID: 9691099
    [Abstract] [Full Text] [Related]

  • 11. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
    Brooks SC, Kazmer S, Levin AA, Yen A.
    Blood; 1996 Jan 01; 87(1):227-37. PubMed ID: 8547646
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.
    Beard RL, Colon DF, Song TK, Davies PJ, Kochhar DM, Chandraratna RA.
    J Med Chem; 1996 Aug 30; 39(18):3556-63. PubMed ID: 8784454
    [Abstract] [Full Text] [Related]

  • 13. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety.
    Ohta K, Iijima T, Kawachi E, Kagechika H, Endo Y.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5913-8. PubMed ID: 15501068
    [Abstract] [Full Text] [Related]

  • 14. [Genetic control of the development by retinoic acid].
    Mark M, Kastner P, Ghyselinck NB, Krezel W, Dupé V, Chambon P.
    C R Seances Soc Biol Fil; 1997 Dec 06; 191(1):77-90. PubMed ID: 9181129
    [Abstract] [Full Text] [Related]

  • 15. Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions.
    Takahashi B, Ohta K, Kawachi E, Fukasawa H, Hashimoto Y, Kagechika H.
    J Med Chem; 2002 Aug 01; 45(16):3327-30. PubMed ID: 12139443
    [Abstract] [Full Text] [Related]

  • 16. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM, Standeven AM, Athanikar J, Kopper S, Castilleja O, Escobar M, Beard RL, Chandraratna RA.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):528-34. PubMed ID: 9262312
    [Abstract] [Full Text] [Related]

  • 17. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A, Shealy YF, Hill DL, Zhang X.
    Cancer Res; 1997 Aug 15; 57(16):3444-50. PubMed ID: 9270011
    [Abstract] [Full Text] [Related]

  • 18. Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists.
    Sato M, Yajima Y, Kawashima S, Tanaka K, Kagechika H.
    Biochem Biophys Res Commun; 2001 Jan 26; 280(3):646-51. PubMed ID: 11162570
    [Abstract] [Full Text] [Related]

  • 19. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
    Ohta K, Kawachi E, Fukasawa H, Shudo K, Kagechika H.
    Bioorg Med Chem; 2011 Apr 15; 19(8):2501-7. PubMed ID: 21459577
    [Abstract] [Full Text] [Related]

  • 20. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
    Standeven AM, Thacher SM, Yuan YD, Escobar M, Vuligonda V, Beard RL, Chandraratna RA.
    Biochem Pharmacol; 2001 Dec 01; 62(11):1501-9. PubMed ID: 11728386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.